Vicarious Surgical Inc. (RBOT) stock
Close on Oct 19, 2026Market cap $142.41KP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Mar 31, 2026
Valuation
- Market cap
- $142.41K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.04
- Dividend yield
- –
- Free cash flow yield
- -31745.86%
Fundamentals
- Net income
- -$42.12M
- EPS, diluted
- -$6.69
- Free cash flow
- -$45.21M
- Book value per share
- $0.50
- Diluted shares
- 7M
Trading
- Previous close
- $0.02
- Open
- $0.00
- Day's range
- $0.00 – $0.71
- Volume
- 52,021
- Average volume (20 days)
- 44,584
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | RBOT | S&P 500 | Difference | RBOT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -35.7% | +0.6% | −36.3 pts | ||
| 3 months | -89.3% | +3.4% | −92.6 pts | ||
| Year to date | -99.1% | +13.3% | −112.4 pts | ||
| 1 year | -99.7% | +16.6% | −116.3 pts | ||
| 3 years | -99.8% | +86.4% | −186.2 pts | -88.0% | +23.1% |
| 5 years | -100.0% | +81.9% | −181.8 pts | -85.7% | +12.7% |
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Vicarious Surgical filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- News
- Update
- Results
- News
About Vicarious Surgical
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Vicarious Surgical Inc. is a medical technology company developing miniaturized robotic systems designed to perform minimally invasive surgery. Its core product candidate, the Vicarious Surgical System, is a single-port surgical robot featuring decoupled actuators, stereoscopic visualization, and sensor-equipped instrument arms that provide human-equivalent motion inside the abdominal cavity. The platform is engineered to enter the abdomen through an incision as small as 1.8 centimeters to support procedures such as ventral hernia repair, as well as gynecological and gastrointestinal interventions. The system's intended customers include hospitals and ambulatory surgical centers seeking flexible, mobile alternatives to conventional multi-port or bulky surgical robotics.
Company profile, executives and historyVicarious Surgical stock: common questions
What is Vicarious Surgical's stock price?
RBOT closed at $0.02 on Oct 19, 2026, up 11.11% on the day.
What is Vicarious Surgical's market cap?
Vicarious Surgical was worth $142.41K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is RBOT's P/E ratio?
Vicarious Surgical lost money over the twelve months to Mar 31, 2026 (diluted EPS -$6.69), so it has no meaningful P/E ratio.
Does Vicarious Surgical pay a dividend?
No. Vicarious Surgical has not paid a cash dividend over the last twelve months.
How has RBOT stock performed over the past year?
Including dividends, RBOT returned -99.7% over the past year, against +16.6% for the S&P 500.
Who are Vicarious Surgical's competitors?
Companies most similar to Vicarious Surgical by business, industry and size include ISRG, MYO, FEED, SMTI, MLSS.
See a number that looks wrong?